Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.

C, explains that proactively managing seasonal allergies can significantly decrease the overall inflammatory burden, thereby improving both physical symptoms and potentially mitigating ...

C, features insights on how unaddressed chronic allergy symptoms contribute to mental health burdens and the critical role of early immunoglobulin E trigger identification in managing both physical ...

Department of Biomedical and Molecular Sciences, Queen’s University, 99 University Avenue, Kingston, Ontario K7L 3N6, Canada Department of Biochemistry, The University of Western Ontario, 1151 ...

Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto606-8501, Japan National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka567-0085, Japan *Tel: +81 ...